SCHEMBL8934567

SCHEMBL8934567

CCCC(=O)Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.58
▸ BCL9 O00512 1/20 0.55
▸ CTNNB1 P35222 1/20 0.55
▸ CYP2C19 P33261 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ MAPT P10636 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MEN1 O00255 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ LOXL2 Q9Y4K0 1/20 0.47
▸ MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14032363 0.87 ALDH1A1 (0.68) ALDH1A1BCL9CTNNB1CYP2C19CYP1A2
SCHEMBL12179295 0.86 CYP2C19 (0.54) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL6932662 0.85 CYP2C19 (0.61) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL11239432 0.85 TSHR (0.56) ALDH1A1BCL9CTNNB1CYP2C19MAPT
SCHEMBL6647402 0.84 TSHR (0.59) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL5496017 0.83 CYP2C19 (0.55) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL24221950 0.81 L3MBTL1 (0.65) ALDH1A1CYP2C19CYP1A2MAPTTSHR
SCHEMBL6808768 0.80 TSHR (0.58) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL11373145 0.79 CYP2C19 (0.54) ALDH1A1CYP2C19CYP1A2MAPTGAA
SCHEMBL22408746 0.79 CYP2C19 (0.54) ALDH1A1CYP2C19CYP1A2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996030350-A1 AMIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-03 — — WO disclosed
Send feedback